About MassCPR

The Massachusetts Consortium on Pathogen Readiness

The Massachusetts Consortium on Pathogen Readiness (MassCPR), led by Harvard Medical School (HMS) in collaboration with biomedical and public partners, is a network of clinicians, scientists, public health professionals, and institutions serving as a convener and catalyst for collaboration across academia, healthcare, and the public sector.

Established in March 2020 to address the urgent challenges of the COVID-19 pandemic, MassCPR has since mobilized a network of hundreds of experts across 25+ institutions, including major academic medical centers, research universities, public health departments, and industry partners. Through this effort, the consortium has helped secure millions in research support, launched 200+ funded projects, and facilitated collaborations that have led to over 1,000 peer-reviewed publications advancing our understanding of infectious diseases.

MassCPR’s work spans several key focus areas:

  • Data integration and surveillance

    A federated research data network links millions of patient records, enabling real-time insight into emerging threats.

  • Clinical and translational research

    Accelerating the path from discovery to intervention.

  • Biobanking and biospecimen sharing

    Providing critical materials to investigators across institutions.

  • Community engagement and education

    Bridging science and the public to build trust and literacy in health research.

  • Policy and public health partnerships

    Aligning scientific discovery with preparedness and response at local, national, and global levels.

Partnership Over Competition

More than a pandemic response, MassCPR pioneered a new model of scientific collaboration—rooted in transparency, shared purpose, and the rapid exchange of knowledge—that prioritizes partnership over competition. What was once considered aspirational in biomedical research became actionable through MassCPR’s unified approach.

Today, the consortium applies this model not only to infectious disease preparedness but also to broader health challenges and complex biomedical questions. By enabling rapid, coordinated responses across sectors, MassCPR offers a strategic advantage that siloed systems cannot match—positioning it as a uniquely capable, collaborative leader in advancing science, public health, and health-system innovation.

Milestones in Action

Since its inception, MassCPR has achieved remarkable milestones—from distributing millions of dollars in research support to advancing our understanding of SARS-CoV-2 biology. Its efforts continue to center on uniting communities, enabling scientific breakthroughs, and expanding both the scope of its work and the partnerships that make that work possible. True to its guiding principle of being “better together,” MassCPR continues to grow, evolve, and contribute meaningfully to scientific progress and public health.

Our Mission and Impact

Support Our Work

Help us stop infectious diseases and strengthen readiness for future outbreaks. As a non-profit, MassCPR relies on the generosity of donors to fund the research and clinical innovation that save lives.

Give Today